GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Marketable Securities

Argenica Therapeutics (ASX:AGN) Marketable Securities : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Argenica Therapeutics's Marketable Securities for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Argenica Therapeutics's annual Marketable Securities increased from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.05 Mil) but then declined from Jun. 2023 (A$0.05 Mil) to Jun. 2024 (A$0.00 Mil).


Argenica Therapeutics Marketable Securities Historical Data

The historical data trend for Argenica Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Marketable Securities Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Marketable Securities
- - 0.05 -

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Marketable Securities Get a 7-Day Free Trial - - 0.05 - -

Argenica Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Argenica Therapeutics  (ASX:AGN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Argenica Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Argenica Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics Headlines

No Headlines